Really? I thought one of the conditions the FDA set was that they had to do new trials on patients using a variety of doses. Don't know where to look this up. But whatever happens, the faster, the better.
:Sign Please:
Yes, that's correct -- they need to do a new trial, with a larger number of patients, using different doses, for a longer period of time.
More info here:
http://www.biospace.com/news_story.aspx?NewsEntityId=164363
I'm glad you improved while on Ampligen, so I really hate to be a Danny-downer here, but I don't think it will ever be approved (in the US at least).
They've been trying to get approval for
almost 30 years, plus the company's CEO has been accused on many occasions of lying to investors in order to boost the stock price. Apparently this happened again last year...where he suggested the FDA was about to approve it "within 2 weeks" (last June), which sent the stock soaring to $4.50 or so. As the summer passed, and there was no approval -- or any word -- from the FDA, the stock price slowly sank -- and then dropped 44% on December 3rd, when the FDA rejected it. It's now at around 48 cents I think...
On a positive note, it does say at this link that it's available in other countries:
http://www.mahalo.com/ampligen